Related Experiment Video
Updated: Mar 9, 2026

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
REP1 inhibits FOXO3-mediated apoptosis to promote cancer cell survival
Kwon-Ho Song1,2,3, Seon Rang Woo1,2,4, Joon-Yong Chung5
1Laboratory of Tumor Immunology, Department of Biomedical Sciences, Graduate School of Medicine, Korea University, Seoul, Republic of Korea.
Abstract:
Rab escort protein 1 (REP1) is a component of Rab geranyl-geranyl transferase 2 complex. Mutations in REP1 cause a disease called choroideremia (CHM), which is an X-linked eye disease. Although it is postulated that REP1 has functions in cell survival or death of various tissues in addition to the eye, how REP1 functions in normal and cancer cells remains to be elucidated. Here, we demonstrated that REP1 is required for the survival of intestinal cells in addition to eyes or a variety of cells in zebrafish, and also has important roles in tumorigenesis. Notably, REP1 is highly expressed in colon cancer tissues and cell lines, and silencing of REP1 sensitizes colon cancer cells to serum starvation- and 5-FU-induced apoptosis. In an effort to elucidate the molecular mechanisms underlying REP1-mediated cell survival under those stress conditions, we identified FOXO3 as a binding partner of REP1 using a yeast two-hybrid (Y2H) assay system, and we demonstrated that REP1 blocked the nuclear trans-localization of FOXO3 through physically interacting with FOXO3, thereby suppressing FOXO3-mediated apoptosis. Importantly, the inhibition of REP1 combined with 5-FU treatment could lead to significant retarded tumor growth in a xenograft tumor model of human cancer cells. Thus, our results suggest that REP1 could be a new therapeutic target in combination treatment for colon cancer patients.
Insights
Rab escort protein 1 (REP1) is crucial for intestinal cell survival and colon cancer progression. Inhibiting REP1 enhances cancer cell apoptosis and retards tumor growth, suggesting REP1 as a therapeutic target.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Rab escort protein 1 (REP1) is a component of the Rab geranyl-geranyl transferase 2 complex.
- Mutations in REP1 cause choroideremia (CHM), an X-linked eye disease.
- REP1's role in normal and cancer cells beyond the eye is not fully understood.
Purpose of the Study:
- To investigate the function of REP1 in intestinal cell survival and tumorigenesis.
- To elucidate the molecular mechanisms of REP1-mediated cell survival.
- To evaluate REP1 as a potential therapeutic target for colon cancer.
Main Methods:
- Yeast two-hybrid (Y2H) assay to identify binding partners.
- Cellular assays to assess apoptosis and nuclear translocation.
- Xenograft tumor models to evaluate therapeutic efficacy.
Main Results:
- REP1 is essential for intestinal cell survival and highly expressed in colon cancer.
- Silencing REP1 sensitizes colon cancer cells to serum starvation and 5-FU-induced apoptosis.
- REP1 interacts with FOXO3, inhibiting its nuclear translocation and suppressing FOXO3-mediated apoptosis.
- Combined inhibition of REP1 and 5-FU significantly retarded tumor growth in vivo.
Conclusions:
- REP1 plays a critical role in colon cancer cell survival and tumorigenesis.
- REP1's interaction with FOXO3 is a key mechanism for its anti-apoptotic function.
- REP1 represents a promising therapeutic target for combination treatment in colon cancer.
More Related Videos
Related Concept Videos
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Negative Regulator Molecules
The Extrinsic Apoptotic Pathway

